Superworth

Diagnostics and research stocks with the highest profit margins

Net income over the last twelve months as a share of revenue. As of .

Ranked
39
of 74 diagnostics and research stocks we cover
Median
−0.9%
Highest
25.9%
CDNA
Range
−82.5% to 25.9%
median −0.9%
−82.5%25.9%
#CompanyNet marginOperating marginRevenue growth (TTM)Market cap
1CDNACareDx25.9%23.4%+38.9%$4.5B
2IDXXIDEXX Laboratories25.0%32.0%+12.8%$52.1B
3MTDMettler-Toledo International21.9%27.8%+6.9%$34.2B
4VCYTVeracyte20.4%18.8%+17.3%$3.9B
5AAgilent Technologies19.5%22.2%+8.6%$49.6B
6ILMNIllumina18.4%19.6%+4.9%$35.7B
7LNTHLantheus17.7%19.4%+2.3%$6.5B
8MEDPMedpace17.7%21.0%+24.7%$18.1B
9DHRDanaher16.9%20.4%+5.5%$162.6B
10TMOThermo Fisher Scientific14.9%17.9%+8.3%$256.9B
11CAICaris Life Sciences10.6%15.5%+85.4%$9.1B
12DGXQuest Diagnostics9.5%14.6%+9.1%$27.5B
13BLLNBillionToOne9.5%10.9%+90.1%$5.2B
14BIOBio-Rad Laboratories8.6%2.1%+1.4%$9.8B
15RVTYRevvity8.2%12.3%+4.1%$16.9B
16IQVIQVIA8.1%13.0%+8.2%$42.5B
17LHLabcorp7.0%10.4%+6.4%$28.9B
18NRCNRC Health4.2%10.5%−0.2%$536.6M
19WATWaters3.6%7.1%+52.5%$46.4B
20RDNTRadNet−0.9%3.1%+18.9%$5.8B
21BRKRBruker−2.0%−0.9%+1.6%$8.5B
22FTREFortrea−2.6%0.5%−3.4%$1.9B
23CSTLCastle Biosciences−5.4%−9.0%+3.2%$1.1B
24CRLCharles River Laboratories International−6.0%2.3%−0.7%$16.2B
25NEOGNeogen−6.3%−0.8%−0.3%$2.6B
26NTRANatera−7.1%−10.7%+37.8%$56.2B
27AVTRAvantor−8.8%−4.6%−1.6%$10.6B
28HBIOHarvard Bioscience−11.9%−0.3%−1.1%$39.1M
29TXG10x Genomics−12.2%−14.3%−4.3%$8B
30MYGNMyriad Genetics−14.0%−12.2%−3.2%$559.6M
31FLGTFulgent Genetics−26.0%−37.7%+6.8%$530.8M
32XGNExagen−26.6%−18.6%+20.8%$203.3M
33BDSXBiodesix−27.0%−20.0%+34.5%$229.8M
34GHGuardant Health−38.3%−39.7%+42.7%$23.7B
35CTKBCytek Biosciences−39.0%−21.6%+5.4%$750M
36QDELQuidelOrtho−39.2%−30.8%−2.5%$962.1M
37MASS908 Devices−57.0%−64.0%+13.4%$422M
38QTRXQuanterix−80.2%−99.6%+22.0%$132.9M
39PACBPacific Biosciences of California−82.5%−83.5%+2.0%$728.9M

Not ranked: 21 with a margin moved by items that are not sales, 5 with under $50M of revenue, 4 with not a meaningful number, 2 with a quarter missing. 3 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.

Net margin for other groups

Other rankings of diagnostics and research stocks

The group